Problem: Individuals with substance use disorder (SUD) have disproportionately higher rates of unintended pregnancy when compared to the general population, estimated to be 85% (Heil et al., 2011). Not only are poor maternal and fetal outcomes associated with unplanned pregnancies, but pregnancies in women with SUD are further complicated by additional risks and adverse outcomes (Black & Day, 2016). Context: Addiction treatment centers and programs are primed with opportunity to offer family planning services, when contact with medical providers is increased for substance use treatment. In response to the opioid crisis and unprecedented rates of unintended pregnancy, this project was designed to identify, develop, and implement an evidence-...
Problem: Opioid use and misuse is a leading cause of injury and death among adolescents and young ad...
Background: Adverse drug events (ADEs) are a significant cause of morbidity and mortality in older a...
In 2012, the Food and Drug Administration approved a combination medication named Truvada (tenofovir...
Background: Advance care planning (ACP) and advance directives (AD) inform the provision of health c...
Background: Primary care (PC) is increasingly the setting for affordable, coordinated, end-to-end pa...
Background: Identifying Mild Cognitive Impairment (MCI) and Alzheimer’s Dementia (AD) in the Primary...
Polypharmacy is a significant healthcare issue among older adults in the United States. It is associ...
Background: Long-acting reversible contraception (LARC) including intrauterine devices (IUDs) are sa...
Abstract There are multiple layers of oversight across the healthcare delivery system. Measuring acu...
Background: Hypertensive disorders during pregnancy have a detrimental effect on maternal and fetal ...
The purpose of this evidence-based change in practice project was to provide nurses with an experien...
Abstract Background: Readmissions after cardiac surgery are often preventable, costly, and potential...
Within the last 10 years, the number of pregnant women with gestational diabetes increased 56%, and ...
This scholarly report describes a Doctorate of Nursing Practice (DNP) project that advanced the perf...
Women with substance use disorders (SUD) face unique barriers to substance use treatment, and as a r...
Problem: Opioid use and misuse is a leading cause of injury and death among adolescents and young ad...
Background: Adverse drug events (ADEs) are a significant cause of morbidity and mortality in older a...
In 2012, the Food and Drug Administration approved a combination medication named Truvada (tenofovir...
Background: Advance care planning (ACP) and advance directives (AD) inform the provision of health c...
Background: Primary care (PC) is increasingly the setting for affordable, coordinated, end-to-end pa...
Background: Identifying Mild Cognitive Impairment (MCI) and Alzheimer’s Dementia (AD) in the Primary...
Polypharmacy is a significant healthcare issue among older adults in the United States. It is associ...
Background: Long-acting reversible contraception (LARC) including intrauterine devices (IUDs) are sa...
Abstract There are multiple layers of oversight across the healthcare delivery system. Measuring acu...
Background: Hypertensive disorders during pregnancy have a detrimental effect on maternal and fetal ...
The purpose of this evidence-based change in practice project was to provide nurses with an experien...
Abstract Background: Readmissions after cardiac surgery are often preventable, costly, and potential...
Within the last 10 years, the number of pregnant women with gestational diabetes increased 56%, and ...
This scholarly report describes a Doctorate of Nursing Practice (DNP) project that advanced the perf...
Women with substance use disorders (SUD) face unique barriers to substance use treatment, and as a r...
Problem: Opioid use and misuse is a leading cause of injury and death among adolescents and young ad...
Background: Adverse drug events (ADEs) are a significant cause of morbidity and mortality in older a...
In 2012, the Food and Drug Administration approved a combination medication named Truvada (tenofovir...